Three centrifugal flow pumps; the Biomedicus BP80, the Sarns Delphin and the Aries Lifestream 2100, were evaluated in vitro to determine each pump's individual tendencies for thrombus formation. Thrombogenic surfaces in the circuit were minimized by using heparin coated tubing and connectors. The centrifugal pumps, which were not heparin bonded, were placed in line in a circuit which consisted ...